Rise of Biobanking in the EU: Evidence from the Framework Programmes

he topic of biobanking has been anchoring in the world and Europe as well. The biobanking field today is characterised by heterogeneous entities that could be classified according to many different categories. This article aims to outline the process of the gradual embedding of the field of biobanking in the European Union (EU) from the point of view of the number of high-quality international research projects related to biobanking or biobanks as such. To identify these research projects, data from the European Commission's (EC's) database on research and innovation projects financed from Framework Programmes (FPs) of the European Union and the Horizon programme were used. It was found that the number of research and innovation projects in which biobanks played an important role more than doubled between 1994 and 2021. The highest increase in the number of biobank-related research and innovation projects occurred between 2002 – 2006 and 2007 – 2013. Several leading countries, in terms of the number of biobank related research projects, emerged during the whole period. The main actors were all countries of western Europe, characterised mostly by above-average performance in indicators such as GDP per capita, Human Development Index (HDI) or Euro Health Consumer Index (EHCI).